Latest Oncopeptides News & Updates
See the latest news and media coverage for Oncopeptides. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotech company developing targeted cancer therapies
oncopeptides.com- Headquarters
- Stockholm, Sweden
- Founded year
- 2000
- Company type
- Public company
- Number of employees
- 80–200
Latest news about Oncopeptides
Company announcements
-
Oncopeptides publishes the 2025 Annual Report
The report highlights progress, Pepaxti growth, and PDC platform potential. It is available as PDF on the website.
-
Oncopeptides announces Annual General Meeting
The meeting occurs on May 21, 2026, in Stockholm. It covers board elections, remuneration guidelines, incentive programs, and share issuance authorization.
-
Oncopeptides publishes real-world evidence on refractory multiple myeloma
Study shows 41% response rate in advanced patients, supports treatment sequencing, and manageable safety in elderly. Reinforces exploring new approaches.
-
Oncopeptides announces updated shares and votes
After rights issue, shares total 395,287,003, with 382,562,006.5 votes. Share capital increases to SEK 43,920,779.894805.
Media coverage
-
FDA Requests Removal of Pepaxto Indication for Multiple Myeloma | Managed Healthcare Executive
Oncopeptides disagrees with the FDA about Pepaxto and will make a decision about next steps by the end of the first quarter of 2023.
-
Redeye lowers motivated value for Oncopeptides to 4.5 kronor (5.5)
By subscribing to the cost-free subscription Affärsvärlden Free, you get a selection of all our material, as well as a daily newsletter with the latest news.
-
After the successes in Europe - aims at new cancer types
Close AD: Oncopeptides - interview with Sofia Heigis, CEO. After gaining a foothold with the drug Pepaxti, Oncopeptides is ready for the next step. The company is investing...
-
After the cool emissions interest - large block traded in Oncopeptides
Stäng Oscarsson on Kinnevik: Dubious about whether short reports should be allowed to exist. On Tuesday, Oncopeptides announced that the guarantors were forced to step in and fill out a new issue after...
Track Oncopeptides and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Oncopeptides competitors & trending companies
Browse news for competitors to Oncopeptides and other trending companies.
Disc Medicine
Aura Biosciences
Repertoire Immune Medicines
Ascelia Pharma
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI